| Date | Description |
| 30 November 2007 | Haddock culture: Current knowledge and challengesThe cod Gadus morhua is receiving the greatest current interest in the diversification of north temperate aquaculture, but the haddock Melanogrammus aeglefinus, a related gadoid species, is another promising ... |
| 25 November 2007 | Step by step guide to a marine water parasite prevention plan (PPP) This article has been prepared as a practical guide-line to help small to medium size marine cage farmers within the Asia-Pacific region cope with common external parasites. Read it as a guide-line ... |
| 22 November 2007 | Infectious salmon anemia (ISA) in Chile, 2007Infectious salmon anemia (ISA) is an infectious disease caused by an orthomyxo-like-virus. It was reported for the first time 24 years ago in Norway. Later ISA was also reported in Canada (New Brunswick ... |
| 21 November 2007 | Intervet Participation in Forthcoming 8th Asian Fisheries Forum in November 2007Reinforcing our continuing commitment to the development of sustainable aquaculture in Asia, Intervet is a proud sponsor 8th Asian Fisheries Forum 2007 which will be held in Kochi, India from November ... |
| 19 November 2007 | Schering-Plough & Intervet - Growing Stronger Growing BetterSchering-Plough Corporation announced on November 19th that it has completed the acquisition of Intervet which is part of Organon BioSciences N.V., creating a stronger combined company with broader human ... |
| 12 - 23 November 2007 | Intervet are proud sponsors of the first Fish Health Master class held in Bangkok, ThailandThe Australian Centre for International Agricultural research (ACIAR) and the Crawford Foundation have come forward to fund a 2-week master class on aquatic animal pathology. The course is coordinated ... |
| 6 November 2007 | AQUAFLOR® (florfenicol) Approved for Controlling Mortality Due to Furunculosis in Freshwater-Reared SalmonidsEfficacy studies show that AQUAFLOR is highly effectiveKENILWORTH, N.J., Nov. 6, 2007 — AQUAFLOR® (florfenicol), the fast-acting in-feed antibiotic developed by Schering-Plough Animal Health Corporation, ... |
| 10 October 2007 | Bacterial diseases of finfish in the South East Asian regionFish mortality associated with infectious disease in South East Asia remains high. Often mortality over a typical production cycle ranges between 20-80%. Due to a general lack of diagnostic capacity, ... |
| 17 - 20 September 2007 | Some impressions from the 13th European Association of Fish Pathologists meetingEric Rijke, Intervet InternationalAround 350 participants attended. The scientific program consisted of 127 oral (parallel sessions) and more than 200 poster presentations.The conference keynote presentation ... |
| 23 - 25 August 2007 | Intervet at the Second International Technical and Trade Conference - Tilapia 2007Intervet was proud to be a silver sponsor of this conference which was held on 23-25 August in Kuala Lumpur, Malaysia. It attracted nearly 300 delegates representing all sectors of the tilapia industry ... |
| 18 - 19 August 2007 | 2007 Symposium – Chinese Society of Fish DiseasesThis symposium was held on August 18th & 19th in Urumqi, XingJiang. Approximately 100 researchers, representing all major research institutes, universities and government agencies, participated in ... |
| 15 August 2007 | The first group of aquatic animal health specialists certified in ChinaAfter an intensive 15-day training, 22 trainees from Guangdong Province successfully passed the exams and received a certificate as aquatic animal health specialists on August 15, 2007. The program consisted ... |
| 14 - 17 August 2007 | Intervet at Aqua Nor 2007The worlds largest exhibition for fish farmers, Aqua Nor, took place from August 14-17 in Trondheim, Norway. As always, Intervet Norbio AS had a booth in the busiest exhibition hall. Intervet Norbio staff ... |
| 5 - 8 August 2007 | Intervet at Asian Pacific Aquaculture 2007.The Asian Pacific chapter of the World Aquaculture Society held its annual meeting in Hanoi, Vietnam from August 5-8. The conference was attended by Dr Yoshinobu Wada, from Intervet KK, Japan, and Drs ... |
| 18 July 2007 | New Global Aquatic Veterinary Association FormedThe first Annual General Meeting of the newly formed Aquatic Veterinary Association (AqVA) will be held on July 18, 2007 in Washington DC, USA, in conjunction with the144th AVMA ANNUAL CONVENTION. Online ... |
| 7 June 2007 | Intervet Inc. (USA) AAH Team Thinks “Outside The Box”AQUAVAC-ESC®, first launched in the USA in 2000, was marketed to the aquaculture industry to prevent Edwardsciella ictaluri from devastating catfish production. The product was effective and profitable ... |
| 5 June 2007 | Caligiasis In The Chilean Salmon Farming IndustryMaria-Jose Birrer (Intervet Chile Ltd.) Caligiasis is a parasitic disease which affects marine fish in Chile. The parasite is endemic and is located in the skin where it feeds from the mucus of the affected ... |
| 3 June 2007 | Duration Of Immunity Of Norvax® Strep Si Under Normal Farming ConditionsDr.Cedric Komar & Dr Lauke Labrie ( Intervet Norbio Singapore)Norvax® Strep Si is a water-based inactivated vaccine against Streptococcus iniae infections in fish. Laboratory studies show that a ... |
| 1 June 2007 | Parasitic Diseases Of TilapiaDr. Cedric Komar and Neil Wendover (Intervet Norbio Singapore)In the last three issues of the Intervet Aquatic Animal Health Newsletter, we presented a series of articles on tilapia diseases: first a ... |
| 16 April 2007 | AQUAFLOR®- CA1 Conditionally Approved By FDA for Controlling Columnaris in CatfishFirst and only catfish antibiotic approved for highly prevalent and costly bacterial disease KENILWORTH, N.J., April 16, 2007 - Schering-Plough Animal Health Corporation has introduced AQUAFLOR®-CA1 ... |
| 15 April 2007 | International Co-operation to Further Knowledge and Understanding of Salmonid AlphavirusesTwo years ago an international group of key salmon industry people and scientists from Ireland, France, Norway and Scotland was set up to speedily advance and address the gaps in our knowledge of pancreas ... |
| 1 April 2007 | Intervet Participates in the 7th International Symposium on Viruses of Lower VertebratesKaren Elina Christie (Intervet Norbio, Bergen) recently gave a talk at the 7th International Symposium on Viruses of Lower Vertebrates in Oslo (Norway) in April, 2007. The topic covered was the development ... |
| 21 March 2007 | AQUAFLOR (florfenicol) Approved for Freshwater-reared SalmonidsFirst and only antibiotic in U.S. for coldwater disease KENILWORTH, N.J., March 21, 2007 AQUAFLOR (florfenicol), the first new in-feed antibiotic licensed for U.S. aquaculture in more than two decades, ... |
| 1 March 2007 | Intervet Aquatic Animal Health at VIV ASIA 2007With the Asia-Pacific region being home to 90% of the world's aquaculture production, the slowing growth of wild capture production and high prices for fish have accelerated aquaculture production in ... |
| 26 February 2007 | Validated assay shows that AQUAFLOR® remains stable in floating or sinking pelleted feed for catfish, salmonidsKey PointsAQUAFLOR® (florfenicol) was tested for stability and consistency after incorporation into pelleted feeds for catfish and salmonids.A validated assay demonstrated that AQUAFLOR survives the high ... |
| 26 February 2007 | Studies demonstrate AQUAFLOR® (florfenicol) efficacy for control of S. iniae mortality in tilapiaKey PointsThe active ingredient in AQUAFLOR® and AQUAFEN® (florfenicol) was tested in a series of controlled studies for efficacy against S. iniae in Nile tilapia.Mortality was reduced with three different ... |
| 26 February 2007 | Management is key to disease control as tilapia producers intensify productionKey PointsTilapia now contract many of the same diseases that affect other fish species, in large part due to intensified production practices.Improved disease control in tilapia hinges on good managementThe ... |
| 26 February 2007 | AQUAVAC™ GARVETIL™ vaccine safely reduces streptococcosis mortality in tilapiaKey PointsA large-scale controlled field trial with AQUAVAC™ GARVETIL™ vaccines was conducted on a commercial tilapia farm experiencing streptococcosis outbreaks.Small fry were immersion-vaccinated with ... |
| 26 February 2007 | AQUAVAC™ ERGOSAN™ in rainbow trout initiates improved vaccine response, stress tolerance and weightKey PointsA controlled study on a commercial rainbow trout farm demonstrated that administration of AQUAVAC™ ERGOSAN™, an immunomodulator, initiated a greater immune response to vaccination with AQUAVAC™ ... |
| 26 February 2007 | AQUAFLOR® offers tilapia producers novel tool for fighting bacterial infections without prolonged withdrawalKey PointsAverage AQUAFLOR® residues in tilapia fall below the tissue- tolerance concentration of 1.0 ppm within 2 days after drug withdrawal.The short withdrawal period possible with AQUAFLOR lets tilapia ... |
